[HTML][HTML] Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Y Wang, Y Chen, J Zhang, Y Yang, JS Fleishman… - Drug Resistance …, 2024 - Elsevier
Cuproptosis is a newly identified form of cell death driven by copper. Recently, the role of
copper and copper triggered cell death in the pathogenesis of cancers have attracted …
copper and copper triggered cell death in the pathogenesis of cancers have attracted …
Recent development of gold (I) and gold (III) complexes as therapeutic agents for cancer diseases
Y Lu, X Ma, X Chang, Z Liang, L Lv, M Shan… - Chemical Society …, 2022 - pubs.rsc.org
Metal complexes have demonstrated significant antitumor activities and platinum complexes
are well established in the clinical application of cancer chemotherapy. However, the …
are well established in the clinical application of cancer chemotherapy. However, the …
Advances of medical nanorobots for future cancer treatments
Early detection and diagnosis of many cancers is very challenging. Late stage detection of a
cancer always leads to high mortality rates. It is imperative to develop novel and more …
cancer always leads to high mortality rates. It is imperative to develop novel and more …
[HTML][HTML] Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents
Selenium is an essential trace element that is crucial for cellular antioxidant defense against
reactive oxygen species (ROS). Recently, many selenium-containing compounds have …
reactive oxygen species (ROS). Recently, many selenium-containing compounds have …
Copper-catalyzed glutathione oxidation is accelerated by the anticancer thiosemicarbazone Dp44mT and further boosted at lower pH
Glutathione (GSH) is the most abundant thiol in mammalian cells and plays a crucial role in
maintaining redox cellular homeostasis. The thiols of two GSH molecules can be oxidized to …
maintaining redox cellular homeostasis. The thiols of two GSH molecules can be oxidized to …
A platinum (IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
P Fronik, M Gutmann, P Vician, M Stojanovic… - Communications …, 2022 - nature.com
Clinical efficacy of oxaliplatin is frequently limited by severe adverse effects and therapy
resistance. Acquired insensitivity to oxaliplatin is, at least in part, associated with elevated …
resistance. Acquired insensitivity to oxaliplatin is, at least in part, associated with elevated …
Amphiphilic dendrimer do** enhanced pH‐sensitivity of liposomal vesicle for effective Co‐delivery toward synergistic ferroptosis–apoptosis therapy of …
Ferroptosis, characterized by the accumulation of reactive oxygen species and lipid
peroxides, has emerged as an attractive strategy to reverse drug resistance. Of particular …
peroxides, has emerged as an attractive strategy to reverse drug resistance. Of particular …
The role of the thioredoxin detoxification system in cancer progression and resistance
The intracellular redox homeostasis is a dynamic balancing system between the levels of
free radical species and antioxidant enzymes and small molecules at the core of cellular …
free radical species and antioxidant enzymes and small molecules at the core of cellular …
Emerging platinum (IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy
S Zheng, G Li, J Shi, X Liu, M Li, Z He, C Tian… - Journal of Controlled …, 2023 - Elsevier
Owing to the unique DNA damaging cytotoxicity, platinum (Pt)-based chemotherapy has
long been the first-line choice for clinical oncology. Unfortunately, Pt drugs are restricted by …
long been the first-line choice for clinical oncology. Unfortunately, Pt drugs are restricted by …
Synthesis and characterization of polypyridine ruthenium (II) complexes and anticancer efficacy studies in vivo and in vitro
L Liang, X Wu, C Shi, H Wen, S Wu, J Chen… - Journal of Inorganic …, 2022 - Elsevier
In this article, ligand IPP (IPP= 4-(1H-imidazo [4, 5-f][1, 10] phenanthrolin-2-yl)-N, N-
diphenylaniline) and its three Ru (II) complexes:[Ru (bpy) 2 (IPP)](ClO 4) 2 (1)(bpy= 2, 2 …
diphenylaniline) and its three Ru (II) complexes:[Ru (bpy) 2 (IPP)](ClO 4) 2 (1)(bpy= 2, 2 …